Inside the Seattle labs of Xaira, the AI-powered startup launched with $1B from investors

Alumis files for IPO to support work on oral TYK2 blockers

Foresite Labs Welcomes Dr. David Weinreich as Operating Partner

Exclusive: In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D